Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 673090, 15 pages
http://dx.doi.org/10.1155/2015/673090
Review Article

Contribution of Microglia-Mediated Neuroinflammation to Retinal Degenerative Diseases

1Centre of Ophthalmology and Vision Sciences, IBILI, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, 3004-548 Coimbra, Portugal
2Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
3Department of Life Sciences, University of Coimbra, Coimbra, Portugal
4AIBILI, Coimbra, Portugal

Received 5 November 2014; Accepted 16 December 2014

Academic Editor: Kiyoshi Matsumura

Copyright © 2015 Maria H. Madeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Simó, M. Villarroel, L. Corraliza, C. Hernández, and M. Garcia-Ramírez, “The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 190724, 15 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. London, I. Benhar, and M. Schwartz, “The retina as a window to the brain—from eye research to CNS disorders,” Nature Reviews Neurology, vol. 9, no. 1, pp. 44–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Nelson, “Visual responses of Ganglion cells,” in Webvision: The Organization of the Retina and Visual System, H. Kolb, E. Fernandez, and R. Nelson, Eds., Salt Lake City, Utah, USA, 1995. View at Google Scholar
  4. A. Reichenbach and A. Bringmann, “New functions of müller cells,” GLIA, vol. 61, no. 5, pp. 651–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bringmann and P. Wiedemann, “Müller glial cells in retinal disease,” Ophthalmologica, vol. 227, no. 1, pp. 1–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kolb, “Glial cells of the retina,” in Webvision: The Organization of the Retina and Visual System [Internet], H. Kolb, E. Fernandez, and R. Nelson, Eds., University of Utah Health Sciences Center, Salt Lake City, Utah, USA, 1995. View at Google Scholar
  7. A. M. Labin, S. K. Safuri, E. N. Ribak, and I. Perlman, “Müller cells separate between wavelengths to improve day vision with minimal effect upon night vision,” Nature Communications, vol. 5, article 4319, 2014. View at Publisher · View at Google Scholar
  8. H. Yao, T. Wang, J. Deng, D. Liu, X. Li, and J. Deng, “The development of blood-retinal barrier during the interaction of astrocytes with vascular wall cells,” Neural Regeneration Research, vol. 9, no. 10, pp. 1047–1054, 2014. View at Publisher · View at Google Scholar
  9. K. Helmut, U.-K. Hanisch, M. Noda, and A. Verkhratsky, “Physiology of microglia,” Physiological Reviews, vol. 91, no. 2, pp. 461–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kettenmann, F. Kirchhoff, and A. Verkhratsky, “Microglia: new roles for the synaptic stripper,” Neuron, vol. 77, no. 1, pp. 10–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Bilimoria and B. Stevens, “Microglia function during brain development: new insights from animal models,” Brain Research, 2014. View at Publisher · View at Google Scholar
  12. D. P. Schafer, E. K. Lehrman, A. G. Kautzman et al., “Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner,” Neuron, vol. 74, no. 4, pp. 691–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Bialas and B. Stevens, “TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement,” Nature Neuroscience, vol. 16, no. 12, pp. 1773–1782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Ashwell, H. Holländer, W. Streit, and J. Stone, “The appearance and distribution of microglia in the developing retina of the rat.,” Visual neuroscience, vol. 2, no. 5, pp. 437–448, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. U. B. Eyo and L.-J. Wu, “Bidirectional microglia-neuron communication in the healthy brain,” Neural Plasticity, vol. 2013, Article ID 456857, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. Carwile, R. B. Culbert, R. L. Sturdivant, and T. W. Kraft, “Rod outer segment maintenance is enhanced in the presence of BFGF, CNTF and GDNF,” Experimental Eye Research, vol. 66, no. 6, pp. 791–805, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Harada, C. Harada, S. Kohsaka et al., “Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration,” Journal of Neuroscience, vol. 22, no. 21, pp. 9228–9236, 2002. View at Google Scholar · View at Scopus
  18. Y. Li, X.-F. Du, C.-S. Liu, Z.-L. Wen, and J.-L. Du, “Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo,” Developmental Cell, vol. 23, no. 6, pp. 1189–1202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Wang and W. T. Wong, “Microglia-Müller cell interactions in the retina,” Advances in Experimental Medicine and Biology, vol. 801, pp. 333–338, 2014. View at Google Scholar
  20. M. Wang, X. Wang, L. Zhao et al., “Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina,” Journal of Neuroscience, vol. 34, no. 10, pp. 3793–3806, 2014. View at Publisher · View at Google Scholar
  21. F. Ginhoux, S. Lim, G. Hoeffel, D. Low, and T. Huber, “Origin and differentiation of microglia,” Frontiers in Cellular Neuroscience, vol. 7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Polazzi and B. Monti, “Microglia and neuroprotection: from in vitro studies to therapeutic applications,” Progress in Neurobiology, vol. 92, no. 3, pp. 293–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Y. Chan, S. Kohsaka, and P. Rezaie, “The origin and cell lineage of microglia—new concepts,” Brain Research Reviews, vol. 53, no. 2, pp. 344–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Butovsky, M. P. Jedrychowski, C. S. Moore et al., “Identification of a unique TGF-β-dependent molecular and functional signature in microglia,” Nature Neuroscience, vol. 17, no. 1, pp. 131–143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. E. L. Gautiar, T. Shay, J. Miller et al., “Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages,” Nature Immunology, vol. 13, no. 11, pp. 1118–1128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Diaz-Araya, J. M. Provis, P. L. Penfold, and F. A. Billson, “Development of microglial topography in human retina,” The Journal of Comparative Neurology, vol. 363, no. 1, pp. 53–68, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Xu, M. Chen, E. J. Mayer, J. V. Forrester, and A. D. Dick, “Turnover of resident retinal microglia in the normal adult mouse,” GLIA, vol. 55, no. 11, pp. 1189–1198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. A. Albini, R. C. Wang, B. Reiser, E. Zamir, G. S. Wu, and N. A. Rao, “Microglial stability and repopulation in the retina,” British Journal of Ophthalmology, vol. 89, no. 7, pp. 901–903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Ajami, J. L. Bennett, C. Krieger, W. Tetzlaff, and F. M. V. Rossi, “Local self-renewal can sustain CNS microglia maintenance and function throughout adult life,” Nature Neuroscience, vol. 10, no. 12, pp. 1538–1543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Chen, J. Zhao, C. Luo et al., “Para-inflammation-mediated retinal recruitment of bone marrow-derived myeloid cells following whole-body irradiation is CCL2 dependent,” Glia, vol. 60, no. 5, pp. 833–842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Huang, J. Cui, L. Li, P. F. Hitchcock, and Y. Li, “The role of microglia in the neurogenesis of zebrafish retina,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 214–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Sierra, J. Navascués, M. A. Cuadros et al., “Expression of inducible nitric oxide synthase (iNOS) in microglia of the developing quail retina,” PLoS ONE, vol. 9, no. 8, Article ID e106048, 2014. View at Publisher · View at Google Scholar
  33. R. M. Ferrer-Martín, D. Martín-Oliva, A. Sierra et al., “Microglial cells in organotypic cultures of developing and adult mouse retina and their relationship with cell death,” Experimental Eye Research, vol. 121, pp. 42–57, 2014. View at Publisher · View at Google Scholar
  34. D. A. Hume, V. H. Perry, and S. Gordon, “Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation in microglial cells to form a regular array in the plexiform layers,” The Journal of Cell Biology, vol. 97, no. 1, pp. 253–257, 1983. View at Publisher · View at Google Scholar · View at Scopus
  35. R. G. Ellis-Behnke, R. A. Jonas, and J. B. Jonas, “The microglial system in the eye and brain in response to stimuli in vivo,” Journal of Glaucoma, vol. 22, pp. S32–S35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. T. Sasmono, D. Oceandy, J. W. Pollard et al., “A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse,” Blood, vol. 101, no. 3, pp. 1155–1163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. D. H. Frankel, B. H. Hanusa, and J. A. Zitelli, “New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin: implications and recommendations for follow-up,” Journal of the American Academy of Dermatology, vol. 26, no. 5, pp. 720–726, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Chen, P. Yang, and A. Kijlstra, “Distribution, markers, and functions of retinal microglia,” Ocular Immunology and Inflammation, vol. 10, no. 1, pp. 27–39, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Provis, C. M. Diaz, and P. L. Penfold, “Microglia in human retina: a heterogeneous population with distinct ontogenies,” Perspectives on Developmental Neurobiology, vol. 3, no. 3, pp. 213–222, 1996. View at Google Scholar · View at Scopus
  40. J. E. Lee, K. J. Liang, R. N. Fariss, and W. T. Wong, “Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy,” Investigative Ophthalmology and Visual Science, vol. 49, no. 9, pp. 4169–4176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Santos, R. Calvente, M. Tassi et al., “Embryonic and postnatal development of microglial cells in the mouse retina,” The Journal of Comparative Neurology, vol. 506, no. 2, pp. 224–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Sobrado-Calvo, M. Vidal-Sanz, and M. P. Villegas-Pérez, “Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor,” The Journal of Comparative Neurology, vol. 501, no. 6, pp. 866–878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Checchin, F. Sennlaub, E. Levavasseur, M. Leduc, and S. Chemtob, “Potential role of microglia in retinal blood vessel formation,” Investigative Ophthalmology and Visual Science, vol. 47, no. 8, pp. 3595–3602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Crehan, J. Hardy, and J. Pocock, “Microglia, Alzheimer's disease, and complement,” International Journal of Alzheimer's Disease, vol. 2012, Article ID 983640, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Sugama, T. Takenouchi, B. P. Cho, T. H. Joh, M. Hashimoto, and H. Kitani, “Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models,” Inflammation & Allergy—Drug Targets, vol. 8, no. 4, pp. 277–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. T. C. Frank-Cannon, L. T. Alto, F. E. McAlpine, and M. G. Tansey, “Does neuroinflammation fan the flame in neurodegenerative diseases?” Molecular Neurodegeneration, vol. 4, no. 1, article 47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Rogers, D. Mastroeni, B. Leonard, J. Joyce, and A. Grover, “Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?” International Review of Neurobiology, vol. 82, pp. 235–246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. M. L. Block and J.-S. Hong, “Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism,” Progress in Neurobiology, vol. 76, no. 2, pp. 77–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. B. Beynon and F. R. Walker, “Microglial activation in the injured and healthy brain: what are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology,” Neuroscience, vol. 225, pp. 162–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. S. David and A. Kroner, “Repertoire of microglial and macrophage responses after spinal cord injury,” Nature Reviews Neuroscience, vol. 12, no. 7, pp. 388–399, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. M. E. Lull and M. L. Block, “Microglial activation and chronic neurodegeneration,” Neurotherapeutics, vol. 7, no. 4, pp. 354–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Pascolini and S. P. Mariotti, “Global estimates of visual impairment: 2010,” British Journal of Ophthalmology, vol. 96, no. 5, pp. 614–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Resnikoff, D. Pascolini, D. Etya'ale et al., “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, pp. 844–851, 2004. View at Google Scholar · View at Scopus
  54. T. Langmann, “Microglia activation in retinal degeneration,” Journal of Leukocyte Biology, vol. 81, no. 6, pp. 1345–1351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Karlstetter, S. Ebert, and T. Langmann, “Microglia in the healthy and degenerating retina: insights from novel mouse models,” Immunobiology, vol. 215, no. 9-10, pp. 685–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Cheung, L. Guo, and M. F. Cordeiro, “Neuroprotection in glaucoma: drug-based approaches,” Optometry and Vision Science, vol. 85, no. 6, pp. E406–E416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Fuse, “Genetic bases for glaucoma,” Tohoku Journal of Experimental Medicine, vol. 221, no. 1, pp. 1–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Chiu, T.-F. Chan, A. Wu, I. Y.-P. Leung, K.-F. So, and R. C.-C. Chang, “Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?” Age, vol. 34, no. 3, pp. 633–649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Qu, D. Wang, and C. L. Grosskreutz, “Mechanisms of retinal ganglion cell injury and defense in glaucoma,” Experimental Eye Research, vol. 91, no. 1, pp. 48–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. R. F. Brubaker, “Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture,” The American Journal of Ophthalmology, vol. 121, no. 5, pp. 473–483, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Baltmr, J. Duggan, S. Nizari, T. E. Salt, and M. F. Cordeiro, “Neuroprotection in glaucoma—is there a future role?” Experimental Eye Research, vol. 91, no. 5, pp. 554–566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. A. C. Bessero and P. G. Clarke, “Neuroprotection for optic nerve disorders,” Current Opinion in Neurology, vol. 23, no. 1, pp. 10–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. F. Cordeiro and L. A. Levin, “Clinical evidence for neuroprotection in glaucoma,” The American Journal of Ophthalmology, vol. 152, no. 5, pp. 715–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Balaiya, J. Edwards, T. Tillis, V. Khetpal, and K. V. Chalam, “Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma,” Clinical Ophthalmology, vol. 5, no. 1, pp. 553–556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Yuan and A. H. Neufeld, “Tumor necrosis factor‐α: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head,” Glia, vol. 32, no. 1, pp. 42–50, 2000. View at Google Scholar
  66. G. Tezel, X. Yang, J. Yang, and M. B. Wax, “Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice,” Brain Research, vol. 996, no. 2, pp. 202–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Tezel and M. B. Wax, “Increased production of tumor necrosis factor-α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells,” Journal of Neuroscience, vol. 20, no. 23, pp. 8693–8700, 2000. View at Google Scholar · View at Scopus
  68. L. Yuan and A. H. Neufeld, “Activated microglia in the human glaucomatous optic nerve head,” Journal of Neuroscience Research, vol. 64, no. 5, pp. 523–532, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Cvenkel, A. N. Kopitar, and A. Ihan, “Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome,” Mediators of Inflammation, vol. 2010, Article ID 939602, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. K.-H. Chen, C.-C. Wu, S. Roy, S.-M. Lee, and J.-H. Liu, “Increased interleukin-6 in aqueous humor of neovascular glaucoma,” Investigative Ophthalmology & Visual Science, vol. 40, no. 11, pp. 2627–2632, 1999. View at Google Scholar · View at Scopus
  71. R. M. Sappington and D. J. Calkins, “Contribution of TRPV1 to microglia-derived IL-6 and NFκB translocation with elevated hydrostatic pressure,” Investigative Ophthalmology and Visual Science, vol. 49, no. 7, pp. 3005–3017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. E. C. Johnson, T. A. Doser, W. O. Cepurna et al., “Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 504–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Chidlow, J. P. M. Wood, A. Ebneter, and R. J. Casson, “Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells,” Neurobiology of Disease, vol. 48, no. 3, pp. 568–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. S. M. Sims, L. Holmgren, H. M. Cathhart, and R. Sappington, “Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina,” American Journal of Neurodegenerative Disease, vol. 1, no. 2, pp. 168–179, 2012. View at Google Scholar
  75. J. Chua, M. Vania, C. M. G. Cheung et al., “Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes,” Molecular Vision, vol. 18, pp. 431–438, 2012. View at Google Scholar · View at Scopus
  76. A. H. Neufeld, S.-I. Kawai, S. Das et al., “Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase,” Experimental Eye Research, vol. 75, no. 5, pp. 521–528, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. K. J. Cho, J. H. Kim, H.-Y. L. Park, and C. K. Park, “Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion,” Brain Research, vol. 1403, pp. 67–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. G. Tezel, L. Y. Li, R. V. Patil, and M. B. Wax, “TNF-α and TNF-α receptor-1 in the retina of normal and glaucomatous eyes,” Investigative Ophthalmology and Visual Science, vol. 42, no. 8, pp. 1787–1794, 2001. View at Google Scholar · View at Scopus
  79. T. Nakazawa, C. Nakazawa, A. Matsubara et al., “Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma,” The Journal of Neuroscience, vol. 26, no. 49, pp. 12633–12641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. M. M. Al-Gayyar and N. M. Elsherbiny, “Contribution of TNF-α to the development of retinal neurodegenerative disorders,” European Cytokine Network, vol. 24, no. 1, pp. 27–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Tezel and M. B. Wax, “Increased production of tumor necrosis factor-α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells,” The Journal of Neuroscience, vol. 20, no. 23, pp. 8693–8700, 2000. View at Google Scholar · View at Scopus
  82. M. Roh, Y. Zhang, Y. Murakami et al., “Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma,” PLoS ONE, vol. 7, no. 7, Article ID e40065, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. L. Markiewicz, I. Majsterek, K. Przybylowska et al., “Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma,” Acta Ophthalmologica, vol. 91, no. 7, pp. e516–e523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. C. Nathan and Q. W. Xie, “Regulation of biosynthesis of nitric oxide,” The Journal of Biological Chemistry, vol. 269, no. 19, pp. 13725–13728, 1994. View at Google Scholar · View at Scopus
  85. U. Förstermann and W. C. Sessa, “Nitric oxide synthases: regulation and function,” European Heart Journal, vol. 33, no. 7, pp. 829–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. A. H. Neufeld, R. Hemandez, and M. Gonzalez, “Nitric oxide synthase in the human glaucomatous optic nerve head,” Archives of Ophthalmology, vol. 115, no. 4, pp. 497–503, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. L. Vidal, F. Díaz, A. Villena, M. Moreno, J. G. Campos, and I. P. D. Vargas, “Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol,” Brain Research Bulletin, vol. 70, no. 4–6, pp. 406–413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Shareef, A. Sawada, and A. H. Neufeld, “Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure,” Investigative Ophthalmology and Visual Science, vol. 40, no. 12, pp. 2884–2891, 1999. View at Google Scholar · View at Scopus
  89. A. H. Neufeld, A. Sawada, and B. Becker, “Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9944–9948, 1999. View at Publisher · View at Google Scholar · View at Scopus
  90. R. M. Sappington and D. J. Calkins, “Pressure-induced regulation of IL-6 in retinal glial cells: Involvement of the ubiquitin/proteasome pathway and NFκB,” Investigative Ophthalmology and Visual Science, vol. 47, no. 9, pp. 3860–3869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. R. M. Sappington, M. Chan, and D. J. Calkins, “Interleukin-6 protects retinal ganglion cells from pressure-induced death,” Investigative Ophthalmology and Visual Science, vol. 47, no. 7, pp. 2932–2942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. F. H. Grus, S. C. Joachim, D. Wuenschig, J. Rieck, and N. Pfeiffer, “Autoimmunity and glaucoma,” Journal of Glaucoma, vol. 17, no. 1, pp. 79–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Reichelt, S. C. Joachim, N. Pfeiffer, and F. H. Grus, “Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension,” Current Eye Research, vol. 33, no. 3, pp. 253–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. S. C. Joachim, N. Pfeiffer, and F. H. Grus, “Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 243, no. 8, pp. 817–823, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. S. C. Joachim, O. W. Gramlich, P. Laspas et al., “Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens,” PLoS ONE, vol. 7, no. 7, Article ID e40616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Laspas, O. W. Gramlich, H. D. Müller et al., “Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 8835–8848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Taylor, C. J. Calder, J. Albon, J. T. Erichsen, M. E. Boulton, and J. E. Morgan, “Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma,” Experimental Eye Research, vol. 92, no. 5, pp. 338–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Tezel, “The role of glia, mitochondria, and the immune system in glaucoma,” Investigative Ophthalmology & Visual Science, vol. 50, no. 3, pp. 1001–1012, 2008. View at Publisher · View at Google Scholar
  99. A. Bosco, M. R. Steele, and M. L. Vetter, “Early microglia activation in a mouse model of chronic glaucoma,” Journal of Comparative Neurology, vol. 519, no. 4, pp. 599–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Ebneter, R. J. Casson, J. P. M. Wood, and G. Chidlow, “Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6448–6460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. E. C. Johnson, Y. Guo, W. O. Cepurna, and J. C. Morrison, “Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models,” Experimental Eye Research, vol. 88, no. 4, pp. 808–815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Pascale, F. Drago, and S. Govoni, “Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough,” Pharmacological Research, vol. 66, no. 1, pp. 19–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Vohra, J. C. Tsai, and M. Kolko, “The role of inflammation in the pathogenesis of glaucoma,” Survey of Ophthalmology, vol. 58, no. 4, pp. 311–320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Bosco, S. D. Crish, M. R. Steele et al., “Early reduction of microglia activation by irradiation in a model of chronic glaucoma,” PLoS ONE, vol. 7, no. 8, Article ID e43602, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. H. A. Quigley, “Experimental glaucoma damage mechanism.,” Archives of Ophthalmology, vol. 101, no. 8, pp. 1301–1302, 1983. View at Google Scholar · View at Scopus
  106. S. Thanos, “The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina,” European Journal of Neuroscience, vol. 3, no. 12, pp. 1189–1207, 1991. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Schuetz and S. Thanos, “Neuro-glial interactions in the adult rat retina after reaxotomy of ganglion cells: examination of neuron survival and phagocytic microglia using fluorescent tracers,” Brain Research Bulletin, vol. 62, no. 5, pp. 391–396, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Zhang, T. T. Lam, and M. O. Tso, “Heterogeneous populations of microglia/macrophages in the retina and their activation after retinal ischemia and reperfusion injury,” Experimental Eye Research, vol. 81, no. 6, pp. 700–709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. D. M. Inman and P. J. Horner, “Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma,” Glia, vol. 55, no. 9, pp. 942–953, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Fan, F. Xu, M. L. Previti et al., “Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid,” The Journal of Neuroscience, vol. 27, no. 12, pp. 3057–3063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. H. Levkovitch-Verbin, Y. Waserzoog, S. Vander, D. Makarovsky, and I. Piven, “Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 252, pp. 761–772, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. S. F. Abcouwer, C. M. Lin, S. Shanmugam, A. Muthusamy, A. J. Barber, and D. A. Antonetti, “Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury,” Journal of Neuroinflammation, vol. 10, article 149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Bosco, D. M. Inman, M. R. Steele et al., “Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma,” Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1437–1446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. A. H. Neufeld, “Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma,” Archives of Ophthalmology, vol. 117, no. 8, pp. 1050–1056, 1999. View at Publisher · View at Google Scholar · View at Scopus
  115. R. Naskar, M. Wissing, and S. Thanos, “Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma,” Investigative Ophthalmology and Visual Science, vol. 43, no. 9, pp. 2962–2968, 2002. View at Google Scholar · View at Scopus
  116. R. de Hoz, B. I. Gallego, A. I. Ramírez et al., “Rod-like microglia are restricted to eyes with laser-induced ocular hypertension but absent from the microglial changes in the contralateral untreated eye,” PLoS ONE, vol. 8, no. 12, Article ID e83733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. B. I. Gallego, J. J. Salazar, R. de Hoz et al., “IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma,” Journal of Neuroinflammation, vol. 9, article 92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Qu and T. C. Jakobs, “The time course of gene expression during reactive gliosis in the optic nerve,” PLoS ONE, vol. 8, no. 6, Article ID e67094, 2013. View at Publisher · View at Google Scholar · View at Scopus
  119. B. Rojas, B. I. Gallego, A. I. Ramirez et al., “Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,” Journal of Neuroinflammation, vol. 11, no. 1, p. 133, 2014. View at Publisher · View at Google Scholar
  120. K. Lmamura, H. Onoe, M. Shimazawa et al., “Molecular imaging reveals unique degenerative changes in experimental glaucoma,” NeuroReport, vol. 20, no. 2, pp. 139–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Shimazawa, Y. Ito, Y. Inokuchi et al., “An alteration in the lateral geniculate nucleus of experimental glaucoma monkeys: in vivo positron emission tomography imaging of glial activation,” PLoS ONE, vol. 7, no. 1, Article ID e30526, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. Y. Ito, M. Shimazawa, Y.-N. Chen et al., “Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys,” Experimental Eye Research, vol. 89, no. 2, pp. 246–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. N. Gupta, L.-C. Ang, L. N. de Tilly, L. Bidaisee, and Y. H. Yücel, “Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex,” The British Journal of Ophthalmology, vol. 90, no. 6, pp. 674–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. N. Gupta, G. Greenberg, L. N. de Tilly, B. Gray, M. Polemidiotis, and Y. H. Yücel, “Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging,” British Journal of Ophthalmology, vol. 93, no. 1, pp. 56–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. A. J. Weber, H. Chen, W. C. Hubbard, and P. L. Kaufman, “Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus,” Investigative Ophthalmology and Visual Science, vol. 41, no. 6, pp. 1370–1379, 2000. View at Google Scholar · View at Scopus
  126. M. Van Lookeren Campagne, J. Lecouter, B. L. Yaspan, and W. Ye, “Mechanisms of age-related macular degeneration and therapeutic opportunities,” The Journal of Pathology, vol. 232, no. 2, pp. 151–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. D. Ardeljan and C.-C. Chan, “Aging is not a disease: distinguishing age-related macular degeneration from aging,” Progress in Retinal and Eye Research, vol. 37, pp. 68–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. H. R. Coleman, C.-C. Chan, F. L. Ferris III, and E. Y. Chew, “Age-related macular degeneration,” The Lancet, vol. 372, no. 9652, pp. 1835–1845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. R. Hera, M. Keramidas, M. Peoc'h, M. Mouillon, J.-P. Romanet, and J.-J. Feige, “Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration,” American Journal of Ophthalmology, vol. 139, no. 4, pp. 589–596, 2005. View at Publisher · View at Google Scholar · View at Scopus
  130. D. Barthelmes, R. Walton, A. E. Campain et al., “Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data,” The British Journal of Ophthalmology, 2014. View at Publisher · View at Google Scholar
  131. L. G. Fritsche, R. N. Fariss, D. Stambolian, G. R. Abecasis, C. A. Curcio, and A. Swaroop, “Age-related macular degeneration: genetics and biology coming together,” Annual Review of Genomics and Human Genetics, vol. 15, no. 1, pp. 151–171, 2014. View at Publisher · View at Google Scholar
  132. L. Ersoy, T. Ristau, M. Hahn et al., “Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older,” Investigative Ophthalmology and Visual Science, vol. 55, no. 3, pp. 1842–1847, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Grassmann, L. G. Fritsche, C. N. Keilhauer, I. M. Heid, and B. H. F. Weber, “Modelling the genetic risk in age-related macular degeneration,” PLoS ONE, vol. 7, no. 5, Article ID e37979, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. K. Horie-Inoue and S. Inoue, “Genomic aspects of age-related macular degeneration,” Biochemical and Biophysical Research Communications, vol. 452, no. 2, pp. 263–275, 2014. View at Publisher · View at Google Scholar
  135. J. N. Cooke Bailey, M. A. Pericak-Vance, and J. L. Haines, “Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration,” Cold Spring Harbor Perspectives in Medicine, vol. 4, no. 12, Article ID a017186, 2014. View at Publisher · View at Google Scholar
  136. L. G. Fritsche, W. Chen, M. Schu et al., “Seven new loci associated with age-related macular degeneration,” Nature Genetics, vol. 45, no. 4, pp. 433–439, 2013. View at Google Scholar
  137. D. H. Anderson, R. F. Mullins, G. S. Hageman, and L. V. Johnson, “A role for local inflammation in the formation of drusen in the aging eye,” American Journal of Ophthalmology, vol. 134, no. 3, pp. 411–431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. L. V. Johnson, W. P. Leitner, M. K. Staples, and D. H. Anderson, “Complement activation and inflammatory processes in drusen formation and age related macular degeneration,” Experimental Eye Research, vol. 73, no. 6, pp. 887–896, 2001. View at Publisher · View at Google Scholar · View at Scopus
  139. P. L. Penfold, M. C. Madigan, M. C. Gillies, and J. M. Provis, “Immunological and aetiological aspects of macular degeneration,” Progress in Retinal and Eye Research, vol. 20, no. 3, pp. 385–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Nita, A. Grzybowski, F. J. Ascaso, and V. Huerva, “Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation),” Mediators of Inflammation, vol. 2014, Article ID 930671, 10 pages, 2014. View at Publisher · View at Google Scholar
  141. P. L. Penfold, J. G. Wong, J. Gyory, and F. A. Billson, “Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration,” Clinical and Experimental Ophthalmology, vol. 29, no. 3, pp. 188–192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. P. G. Theodossiadis, V. S. Liarakos, P. P. Sfikakis, I. A. Vergados, and G. P. Theodossiadis, “Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration,” American Journal of Ophthalmology, vol. 147, no. 5, pp. 825.e1–830.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. P. G. Theodossiadis, N. N. Markomichelakis, and P. P. Sfikakis, “Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation,” Retina, vol. 27, no. 4, pp. 399–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Giganti, P. M. Beer, N. Lemanski, C. Hartman, J. Schartman, and N. Falk, “Adverse events after intravitreal infliximab (Remicade),” Retina, vol. 30, no. 1, pp. 71–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. A. Mirshahi, R. Hoehn, K. Lorenz, C. Kramann, and H. Baatz, “Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts,” Journal of Ophthalmic and Vision Research, vol. 7, no. 1, pp. 39–44, 2012. View at Google Scholar · View at Scopus
  146. P. G. Theodossiadis, V. S. Liarakos, P. P. Sfikakis et al., “Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 2, pp. 273–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. V. Lambert, J. Lecomte, S. Hansen et al., “Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice,” Nature Protocols, vol. 8, no. 11, pp. 2197–2211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  148. K. Izumi-Nagai, N. Nagai, K. Ohgami et al., “Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1679–1685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. C. Combadière, C. Feumi, W. Raoul et al., “CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration,” The Journal of Clinical Investigation, vol. 117, no. 10, pp. 2920–2928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. T. A. Krause, A. F. Alex, D. R. Engel, C. Kurts, and N. Eter, “VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization,” PLoS ONE, vol. 9, no. 4, Article ID e94313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. H. Huang, R. Parlier, J.-K. Shen, G. A. Lutty, and S. A. Vinores, “VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV,” PLoS ONE, vol. 8, no. 8, Article ID e71808, 2013. View at Publisher · View at Google Scholar · View at Scopus
  152. L. K. Cheung and A. Eaton, “Age-related macular degeneration.,” Pharmacotherapy, vol. 33, no. 8, pp. 838–855, 2013. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Karlstetter and T. Langmann, “Microglia in the aging retina,” in Retinal Degenerative Diseases, vol. 801 of Advances in Experimental Medicine and Biology, pp. 207–212, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  154. M. R. Damani, L. Zhao, A. M. Fontainhas, J. Amaral, R. N. Fariss, and W. T. Wong, “Age-related alterations in the dynamic behavior of microglia,” Aging Cell, vol. 10, no. 2, pp. 263–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. H. Xu, M. Chen, A. Manivannan, N. Lois, and J. V. Forrester, “Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice,” Aging Cell, vol. 7, no. 1, pp. 58–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. F. Cruz-Guilloty, A. M. Saeed, J. J. Echegaray et al., “Infiltration of proinflammatory M1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration,” International Journal of Inflammation, vol. 2013, Article ID 503725, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. J. G. Hollyfield, V. L. Perez, and R. G. Salomon, “A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 290–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. M. C. Killingsworth, J. P. Sarks, and S. H. Sarks, “Macrophages related to Bruch's membrane in age-related macular degeneration,” Eye, vol. 4, no. 4, pp. 613–621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  159. P. L. Penfold, S. C. K. Liew, M. C. Madigan, and J. M. Provis, “Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 38, no. 10, pp. 2125–2133, 1997. View at Google Scholar · View at Scopus
  160. N. Gupta, K. E. Brown, and A. H. Milam, “Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration,” Experimental Eye Research, vol. 76, no. 4, pp. 463–471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. G. Coscas, U. de Benedetto, F. Coscas et al., “Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration,” Ophthalmologica, vol. 229, no. 1, pp. 32–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  162. J. Tuo, B. C. Smith, C. M. Bojanowski et al., “The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration,” The FASEB Journal, vol. 18, no. 11, pp. 1297–1299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  163. C. C. Chan, J. Tuo, C. M. Bojanowski, K. G. Csaky, and W. R. Green, “Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration,” Histology and Histopathology, vol. 20, no. 3, pp. 857–863, 2005. View at Google Scholar · View at Scopus
  164. W. Raoul, C. Auvynet, S. Camelo et al., “CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration,” Journal of Neuroinflammation, vol. 7, article 87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. F. Sennlaub, C. Auvynet, B. Calippe et al., “CCR2+ monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice,” EMBO Molecular Medicine, vol. 5, no. 11, pp. 1775–1793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  166. M. P. Kawa, A. Machalinska, D. Roginska, and B. Machalinski, “Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue,” Journal of Immunology Research, vol. 2014, Article ID 483960, 12 pages, 2014. View at Publisher · View at Google Scholar
  167. W. Ma, R. Cojocaru, N. Gotoh et al., “Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation,” Neurobiology of Aging, vol. 34, no. 10, pp. 2310–2321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  168. S. M. Cashman, A. Desai, K. Ramo, and R. Kumar-Singh, “Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina,” Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3436–3445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. X. Zhan, D. E. Larson, C. Wang et al., “Identification of a rare coding variant in complement 3 associated with age-related macular degeneration,” Nature Genetics, vol. 45, no. 11, pp. 1375–1379, 2013. View at Google Scholar
  170. J. M. Seddon, Y. Yu, E. C. Miller et al., “Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration,” Nature Genetics, vol. 45, no. 11, pp. 1366–1373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. E. C. Schramm, S. J. Clark, M. P. Triebwasser, S. Raychaudhuri, J. M. Seddon, and J. P. Atkinson, “Genetic variants in the complement system predisposing to age-related macular degeneration: a review,” Molecular Immunology, vol. 61, no. 2, pp. 118–125, 2014. View at Publisher · View at Google Scholar
  172. M. Rutar, R. Natoli, P. Kozulin, K. Valter, P. Gatenby, and J. M. Provis, “Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia/macrophages is associated with focal photoreceptor degeneration,” Investigative Ophthalmology and Visual Science, vol. 52, no. 8, pp. 5347–5358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. M. Rutar, K. Valter, R. Natoli, and J. M. Provis, “Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina,” PLoS ONE, vol. 9, no. 4, Article ID e93343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  174. W. Ma, S. Coon, L. Zhao, R. N. Fariss, and W. T. Wong, “A2E accumulation influences retinal microglial activation and complement regulation,” Neurobiology of Aging, vol. 34, no. 3, pp. 943–960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, Supplement 1, pp. S62–S69, 2009. View at Publisher · View at Google Scholar
  176. D. S. Fong, L. Aiello, T. W. Gardner et al., “Diabetic retinopathy,” Diabetes Care, vol. 26, supplement 1, pp. S99–S102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Cunha-Vaz, J. R. F. de Abreu, and A. J. Campos, “Early breakdown of the blood retinal barrier in diabetes,” British Journal of Ophthalmology, vol. 59, no. 11, pp. 649–656, 1975. View at Publisher · View at Google Scholar · View at Scopus
  178. A. J. Barber, “A new view of diabetic retinopathy: a neurodegenerative disease of the eye,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  179. A. R. Santiago, A. J. Cristóvão, P. F. Santos, C. M. Carvalho, and A. F. Ambrósio, “High glucose induces caspase-independent cell death in retinal neural cells,” Neurobiology of Disease, vol. 25, no. 3, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  180. H. P. Hammes, H. J. Federoff, and M. Brownlee, “Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes,” Molecular Medicine, vol. 1, no. 5, pp. 527–534, 1995. View at Google Scholar · View at Scopus
  181. L. A. Kerrigan, D. J. Zack, H. A. Quigley, S. D. Smith, and M. E. Pease, “TUNEL-positive ganglion cells in human primary open-angle glaucoma,” Archives of Ophthalmology, vol. 115, no. 8, pp. 1031–1035, 1997. View at Publisher · View at Google Scholar · View at Scopus
  182. S. E. Simonsen, “The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy,” Acta Ophthalmologica, vol. 58, no. 6, pp. 865–878, 1980. View at Google Scholar · View at Scopus
  183. J. Kizawa, S. Machida, T. Kobayashi, Y. Gotoh, and D. Kurosaka, “Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy,” Japanese Journal of Ophthalmology, vol. 50, no. 4, pp. 367–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  184. A. Reis, C. Mateus, P. Melo, J. Figueira, J. Cunha-Vaz, and M. Castelo-Branco, “Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes,” Diabetes, vol. 63, no. 11, pp. 3926–3937, 2014. View at Publisher · View at Google Scholar
  185. K. Mihály, S. Tóth, L. Szlávik, A. Tóth, and P. Csermely, “Attenuation of diabetic retinopathy by the molecular chaperone-inducer amino acid analogue canavanine in streptozotocin-diabetic rats,” Cellular and Molecular Life Sciences, vol. 54, no. 10, pp. 1154–1160, 1998. View at Publisher · View at Google Scholar · View at Scopus
  186. H. Matsubara, M. Kuze, M. Sasoh, N. Ma, M. Furuta, and Y. Uji, “Time-dependent course of electroretinograms in the spontaneous diabetic Goto-Kakizaki rat,” Japanese Journal of Ophthalmology, vol. 50, no. 3, pp. 211–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  187. H. W. van Dijk, F. D. Verbraak, P. H. B. Kok et al., “Early neurodegeneration in the retina of type 2 diabetic patients,” Investigative Ophthalmology and Visual Science, vol. 53, no. 6, pp. 2715–2719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  188. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. R. M. Brucklacher, K. M. Patel, H. D. VanGuilder et al., “Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response,” BMC Medical Genomics, vol. 1, article 26, 2008. View at Publisher · View at Google Scholar
  190. A. M. A. El Asrar, D. Maimone, P. H. Morse, S. Gregory, and A. T. Reder, “Cytokines in the vitreous of patients with proliferative diabetic retinopathy,” The American Journal of Ophthalmology, vol. 114, no. 6, pp. 731–736, 1992. View at Publisher · View at Google Scholar · View at Scopus
  191. N. Demircan, B. G. Safran, M. Soylu, A. A. Ozcan, and S. Sizmaz, “Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy,” Eye, vol. 20, no. 12, pp. 1366–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  192. Y. Liu, M. B. Costa, and C. Gerhardinger, “IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation,” PLoS ONE, vol. 7, no. 5, Article ID e36949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  193. H. Funatsu, H. Yamashita, H. Noma, T. Mimura, T. Yamashita, and S. Hori, “Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema,” American Journal of Ophthalmology, vol. 133, no. 1, pp. 70–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. C. A. Aveleira, C. M. Lin, S. F. Abcouwer, A. F. Ambrosio, and D. A. Antonetti, “TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability,” Diabetes, vol. 59, no. 11, pp. 2872–2882, 2010. View at Google Scholar
  195. J. D. Luna, C.-C. Chan, N. L. Derevjanik et al., “Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor α, and interleukin-1β-mediated breakdown,” Journal of Neuroscience Research, vol. 49, no. 3, pp. 268–280, 1997. View at Publisher · View at Google Scholar
  196. K. Koizumi, V. Poulaki, S. Doehmen et al., “Contribution of TNF-α to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo,” Investigative Ophthalmology and Visual Science, vol. 44, no. 5, pp. 2184–2191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  197. M. P. Boldin, T. M. Goncharov, Y. V. Goltsev, and D. Wallach, “Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death,” Cell, vol. 85, no. 6, pp. 803–815, 1996. View at Publisher · View at Google Scholar · View at Scopus
  198. A. M. Joussen, S. Doehmen, M. L. Le et al., “TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations,” Molecular Vision, vol. 15, pp. 1418–1428, 2009. View at Google Scholar · View at Scopus
  199. A. M. Joussen, V. Poulaki, A. Tsujikawa et al., “Suppression of diabetic retinopathy with angiopoietin-1,” The American Journal of Pathology, vol. 160, no. 5, pp. 1683–1693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  200. Y. Behl, P. Krothapalli, T. Desta, S. Roy, and D. T. Graves, “FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats,” Diabetes, vol. 58, no. 4, pp. 917–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  201. Y. Behl, P. Krothapalli, T. Desta, A. DiPiazza, S. Roy, and D. T. Graves, “Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy,” The American Journal of Pathology, vol. 172, no. 5, pp. 1411–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  202. G. N. Costa, J. Vindeirinho, C. Cavadas, A. F. Ambrósio, and P. F. Santos, “Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose,” Molecular and Cellular Neuroscience, vol. 50, no. 1, pp. 113–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  203. J. K. Krady, A. Basu, C. M. Allen et al., “Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy,” Diabetes, vol. 54, no. 5, pp. 1559–1565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  204. R. A. Kowluru and S. Odenbach, “Role of interleukin-1β in the pathogenesis of diabetic retinopathy,” The British Journal of Ophthalmology, vol. 88, no. 10, pp. 1343–1347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  205. A. Carmo, J. G. Cunha-Vaz, A. P. Carvalho, and M. C. Lopes, “Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability,” Nitric Oxide, vol. 4, no. 6, pp. 590–596, 2000. View at Publisher · View at Google Scholar · View at Scopus
  206. C. A. Dinarello, “Biologic basis for interleukin-1 in disease,” Blood, vol. 87, no. 6, pp. 2095–2147, 1996. View at Google Scholar · View at Scopus
  207. S. Mohr, A. Xi, J. Tang, and T. S. Kern, “Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients,” Diabetes, vol. 51, no. 4, pp. 1172–1179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  208. J. A. Vincent and S. Mohr, “Inhibition of caspase-1/interleukin-1β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia,” Diabetes, vol. 56, no. 1, pp. 224–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  209. C. Aveleira, Á. Castilho, F. Baptista et al., “High glucose and interleukin-1β downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism,” Cytokine, vol. 49, no. 3, pp. 279–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. A. Carmo, J. G. Cunha-Vaz, A. P. Carvalho, and M. C. Lopes, “Effect of cyclosporin-A on the blood-retinal barrier permeability in streptozotocin-induced diabetes,” Mediators of Inflammation, vol. 9, no. 5, pp. 243–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  211. S. D. Bamforth, S. L. Lightman, and J. Greenwood, “Interleukin-1β-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine,” The American Journal of Pathology, vol. 150, no. 1, pp. 329–340, 1997. View at Google Scholar · View at Scopus
  212. A. B. El-Remessy, M. Ali Behzadian, G. Abou-Mohamed, T. Franklin, R. W. Caldwell, and R. B. Caldwell, “Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor,” The American Journal of Pathology, vol. 162, no. 6, pp. 1995–2004, 2003. View at Publisher · View at Google Scholar · View at Scopus
  213. M. Takeda, F. Mori, A. Yoshida et al., “Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats,” Diabetologia, vol. 44, no. 8, pp. 1043–1050, 2001. View at Publisher · View at Google Scholar · View at Scopus
  214. E. C. Leal, A. Manivannan, K.-I. Hosoya et al., “Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5257–5265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  215. L. Zheng, Y. Du, C. Miller et al., “Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes,” Diabetologia, vol. 50, no. 9, pp. 1987–1996, 2007. View at Publisher · View at Google Scholar · View at Scopus
  216. S. Omri, F. Behar-Cohen, Y. de Kozak et al., “Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model,” The American Journal of Pathology, vol. 179, no. 2, pp. 942–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  217. E. Rungger-Brändle, A. A. Dosso, and P. M. Leuenberger, “Glial reactivity, an early feature of diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1971–1980, 2000. View at Google Scholar · View at Scopus
  218. X.-X. Zeng, Y.-K. Ng, and E.-A. Ling, “Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats,” Visual Neuroscience, vol. 17, no. 3, pp. 463–471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  219. A. J. Barber, D. A. Antonetti, T. S. Kern et al., “The Ins2Akita mouse as a model of early retinal complications in diabetes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 6, pp. 2210–2218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  220. H.-Y. Zeng, W. R. Green, and M. O. M. Tso, “Microglial activation in human diabetic retinopathy,” Archives of Ophthalmology, vol. 126, no. 2, pp. 227–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  221. D. Gaucher, J. A. Chiappore, M. Pâques et al., “Microglial changes occur without neural cell death in diabetic retinopathy,” Vision Research, vol. 47, no. 5, pp. 612–623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  222. S. Vujosevic, S. Bini, G. Midena, M. Berton, E. Pilotto, and E. Midena, “Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT,” Journal of Diabetes Research, vol. 2013, Article ID 491835, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  223. A. S. Ibrahim, M. M. El-Shishtawy, A. Peña Jr., and G. I. Liou, “Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation,” Molecular Vision, vol. 16, pp. 2033–2042, 2010. View at Google Scholar · View at Scopus
  224. C. A. Cukras, P. Petrou, E. Y. Chew, C. B. Meyerle, and W. T. Wong, “Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study,” Investigative Ophthalmology and Visual Science, vol. 53, no. 7, pp. 3865–3874, 2012. View at Publisher · View at Google Scholar · View at Scopus
  225. I. U. Scott, G. R. Jackson, D. A. Quillen et al., “Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial,” JAMA Ophthalmology, vol. 132, no. 5, pp. 535–543, 2014. View at Publisher · View at Google Scholar · View at Scopus